Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation

Andrew Chi, MD, PhD at NYU Explains Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation. Author: Cancer-News Added: 03/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts